Hongsheng Cheng

631 total citations
13 papers, 467 citations indexed

About

Hongsheng Cheng is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Hongsheng Cheng has authored 13 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Hongsheng Cheng's work include Cancer therapeutics and mechanisms (5 papers), Cancer Treatment and Pharmacology (3 papers) and RNA regulation and disease (2 papers). Hongsheng Cheng is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Cancer Treatment and Pharmacology (3 papers) and RNA regulation and disease (2 papers). Hongsheng Cheng collaborates with scholars based in United States, China and Japan. Hongsheng Cheng's co-authors include Karen TenDyke, Bruce A. Littlefield, Murray J. Towle, Galina Kuznetsov, Melvin J. Yu, Takanori Kawamura, Diana Liu, Yoshito Kishi, Junke Liu and Lynn D. Hawkins and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Hongsheng Cheng

13 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongsheng Cheng United States	9	239	170	88	84	78	13	467
Pascal Furet Switzerland	7	247 1.0×	397 2.3×	189 2.1×	41 0.5×	32 0.4×	7	565
Somhairle MacCormick United Kingdom	7	441 1.8×	677 4.0×	104 1.2×	78 0.9×	33 0.4×	10	801
Qinhuai Lai China	11	143 0.6×	226 1.3×	149 1.7×	44 0.5×	35 0.4×	18	455
Daniel P. Camarco United States	13	127 0.5×	159 0.9×	118 1.3×	28 0.3×	38 0.5×	21	415
Xiuxian Jiang United Kingdom	7	103 0.4×	227 1.3×	53 0.6×	35 0.4×	31 0.4×	8	635
Behnaz Ahangarian Abhari Germany	15	152 0.6×	555 3.3×	55 0.6×	42 0.5×	26 0.3×	26	699
Deanna N. Parke United States	11	165 0.7×	192 1.1×	130 1.5×	39 0.5×	28 0.4×	18	432
Mingxuan Xia United States	6	307 1.3×	346 2.0×	45 0.5×	63 0.8×	11 0.1×	13	502
Lisa Polin United States	12	111 0.5×	234 1.4×	100 1.1×	42 0.5×	48 0.6×	19	392
Thelma Thompson United States	5	300 1.3×	354 2.1×	60 0.7×	47 0.6×	13 0.2×	6	466

Countries citing papers authored by Hongsheng Cheng

Since Specialization

Citations

This map shows the geographic impact of Hongsheng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongsheng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongsheng Cheng more than expected).

Fields of papers citing papers by Hongsheng Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongsheng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongsheng Cheng. The network helps show where Hongsheng Cheng may publish in the future.

Co-authorship network of co-authors of Hongsheng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongsheng Cheng. A scholar is included among the top collaborators of Hongsheng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongsheng Cheng. Hongsheng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mei, Lingyun, Fen Tang, Jia‐Da Li, et al.. (2020). Identification and functional analysis of a novel missense mutation of PAX3 associated with Waardenburg syndrome type I. European Archives of Oto-Rhino-Laryngology. 278(8). 2807–2815. 2 indexed citations

Booher, Robert N., Maria Samson, Guang-Xin Xu, Hongsheng Cheng, & David Tuck. (2017). Abstract 1168: Efficacy of the IRAK4 inhibitor CA-4948 in patient-derived xenograft models of diffuse large B cell lymphoma. Cancer Research. 77(13_Supplement). 1168–1168. 8 indexed citations

An, Chihui, Karen TenDyke, Hongsheng Cheng, et al.. (2016). Design, Synthesis, and Evaluation of Irciniastatin Analogues: Simplification of the Tetrahydropyran Core and the C(11) Substituents. The Journal of Organic Chemistry. 81(5). 1930–1942. 8 indexed citations

Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo. Bioorganic & Medicinal Chemistry Letters. 21(6). 1634–1638. 12 indexed citations

Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1639–1643. 16 indexed citations

Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility. Bioorganic & Medicinal Chemistry Letters. 21(6). 1630–1633. 16 indexed citations

Smith, Amos B., Onur Atasoylu, Clay S. Bennett, et al.. (2011). Design, Synthesis, and Biological Evaluation of Diminutive Forms of (+)-Spongistatin 1: Lessons Learned. Journal of the American Chemical Society. 133(35). 14042–14053. 24 indexed citations

Li, Jingzhi, Shuhui Wang, Hongsheng Cheng, et al.. (2009). Mutations of <I>Cx26</I> gene in patients with NSHL and intracellular distribution of two mutants. Hereditas (Beijing). 31(7). 705–712. 4 indexed citations

Kuznetsov, Galina, Karen TenDyke, Murray J. Towle, et al.. (2009). Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin. Molecular Cancer Therapeutics. 8(10). 2852–2860. 53 indexed citations

10.

Liu, Junke, Murray J. Towle, Hongsheng Cheng, et al.. (2007). In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.. PubMed. 27(3B). 1509–18. 63 indexed citations

11.

Rudolph‐Owen, Laura A., Kathleen A. Salvato, Hongsheng Cheng, et al.. (2004). A 96-well plate cell-based assay to quantify undesired cytotoxic effects against quiescent non-dividing cells. Cancer Research. 64. 264–265. 3 indexed citations

12.

Kuznetsov, Galina, Murray J. Towle, Hongsheng Cheng, et al.. (2004). Induction of Morphological and Biochemical Apoptosis following Prolonged Mitotic Blockage by Halichondrin B Macrocyclic Ketone Analog E7389. Cancer Research. 64(16). 5760–5766. 216 indexed citations

13.

Przetak, Melinda, Jesse C. Chow, Hongsheng Cheng, et al.. (2003). Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice. Vaccine. 21(9-10). 961–970. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact